key: cord-0859722-qqbq29en
authors: Temiz, Selami Aykut; Abdelmaksoud, Ayman; Dursun, Recep; Durmaz, Koray; Sadoughifar, Roxanna; Hasan, Abdulkarim
title: Pityriasis rosea following SARS‐CoV‐2 vaccination: A case series
date: 2021-08-07
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14372
sha: 1b7cbc393e898e106a7590ec37c74627413a7353
doc_id: 859722
cord_uid: qqbq29en

nan

The authors confirm that the ethical policies of the journal have been adhered to. No ethical approval was required as this is a retrospective review of PR-cases with no original research data.

The data that supports the findings of this study are available in the supplementary material of this article.

Ayman Abdelmaksoud MD 2

Viral exanthem in COVID-19, a clinical enigma with biological significance

Public trust and willingness to vaccinate against COVID-19 in the US from

COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: a report of 2 cases

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19

Pityriasis rosea developing after COVID-19 vaccination

Cutaneous reactions after SARS-COV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases

Pityriasis rosea and pityriasis rosea-like eruptions: how to distinguish them?

Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature

Pityriasis rosea after mRNA COVID-19 vaccination

Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report

Pityriasis rosea following SARS-CoV-2 vaccination: A case series